Last reviewed · How we verify

NCT05050058

Echocardiographic Findings in Infants of Diabetic Mothers and Its Relation to Maternal Glycemic Control

Completed Last updated 30 November 2022
What this trial tests

trial in Infant of Diabetic Mother in 50 participants. Completed in 20 June 2021.

Timeline
8 March 2020
Primary endpoint
12 June 2021
20 June 2021

Quick facts

Lead sponsorMarwa Mohamed Farag
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date8 March 2020
Primary completion12 June 2021
Estimated completion20 June 2021
Sites1 location across Egypt

Conditions studied

Sponsor

Marwa Mohamed Farag — full company profile →

Who can join

Adults 0 Days to 7 Days, any sex, with Infant of Diabetic Mother. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this work was to: 1. Evaluate the use of echocardiography in the assessment of hemodynamic stability in newborns. 2. Determine the prevalence of congenital heart diseases or any cardiac abnormalities in infants born to diabetic mother in relation to the glycemic control of their mothers

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infant of Diabetic Mother

Currently open trials in the same condition.

Other Marwa Mohamed Farag trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05050058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing